Lloyd grew up in Jim CrowVirginia and went to West Virginia State, where he was the star of the school’s championship basketball team. He didn’t know he’d been drafted by the NBA until he ran into a friend on campus who told him she’d heard a rumor that he’d be moving to Washington. It turned out that the Capitols had picked him in the ninth round of the draft. Two other Black players joined the NBA that season—the Celtics drafted Chuck Cooper in the second round and the New York Knicks got Nat “Sweetwater” Clifton from the Harlem Globetrotters—but the Knicks and the Celts didn’t start their seasons until November. As a result, Lloyd became a coincidental pioneer: the first Black player to make his debut in the NBA.
Joining an all-white team was intimidating, Lloyd remembered, but his teammates—most of whom had played on integrated college teams—were immediately welcoming. Some fans, however, were less kind. As the announcer read the Capitols’ lineup on that first night of the season, a white man in the front row used a racial slur
On October 30, 1974, 32-year-old Muhammad Ali becomes the heavyweight champion of the world for the second time when he knocks out 25-year-old champ George Foreman in the eighth round of the “Rumble in the Jungle,” a match in Kinshasa, Zaire. Seven years before, Ali had lost his title when the government accused him of draft-dodging and the boxing commission took away his license. His victory in Zaire made him only the second dethroned champ in history to regain his belt.
The “Rumble in the Jungle” (named by promoter Don King, who’d initially tagged the bout “From the Slave Ship to the Championship!” until Zaire’s president caught wind of the idea and ordered all the posters burned) was Africa’s first heavyweight championship match. The government of the West African republic staged the event—its president, Mobutu Sese Seko, personally paid each of the fighters $5 million simply for showing up—in hopes that it would draw the world’s attention to the country’s enormous beauty and vast reserves of natural resources. Ali agreed. “I wanted to establish a relationship between American blacks and Africans,” he wrote later. “The fight was about racial problems, Vietnam. All of that.” He added: “The Rumble in the Jungle was a fight that made the whole country more conscious.”
If a water bead is ingested, it expands and can pose ingestion, choking and intestinal obstruction hazards inside a child’s body, resulting in severe discomfort, vomiting, dehydration and a risk of death to a child.
When using the recalled bath toys, particularly in a bathtub or wading pool, a child can slip and fall or sit onto the hard plastic top fin of the shark, posing risks of impalement, lacerations and punctures.
The activity table contains a silver metal bell which can detach from its metal arch, posing a choking hazard to young children.
** TARGET
Ouwoer Direct Kids Bike Helmet due to risk of head injury.
Primark Children’s Bamboo Plates due to risk of lead and chemical exposure hazards.
Smocked Runway Whimsy Children’s Pajamas due to violation of federal flammability standards and burn hazard.
Patagonia Infant Capilene Base Layer due to choking hazard.
Clark Associates Lancaster Table & Seating High Chairs due to fall hazard.
Kids Preferred “My First” Disney-Character Figurines due to choking hazard.
Betsy & Lace Children’s Nightgowns due to violation of federal flammability standards and burn hazard.
Hatley USA Children’s Pajamas due to violation of federal flammability standards and burn hazard and children’s headbands due to violation of federal lead content ban.
Oaks Apparel Company Children’s Nightgowns due to violation of federal flammability standards and burn hazards.
WALMART
** The activity centers were sold between November 2020 and October 2023 for about $70.
Recalled model numbers are WA105FZW and WA105GML.
Contact Dorel Juvenile Group for a replacement.
Consumers who have the recalled items will be instructed to cut through the straps of the activity centers and send a photo of the cut straps to Dorel to receive a free replacement.
Dorel can be reached toll-free at 877-657-9546 from 8 a.m. to 6 p.m., Monday through Thursday, and 8 a.m. to 4:30 p.m. Friday ET, or by email at CoscoActivityCenterRecall@djgusa.com
The company can also be reached online at coscokids.com/ or safety1st.com/us-en/. Click on “Safety Notices and Recalls” at the top of the page for more information.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert due to concerns that ready-to-eat (RTE) ham products produced by Sunnyvalley Smoked Meats, a Manteca, Calif. establishment, may be contaminated with Listeria monocytogenes. A recall was not requested because it is believed that the affected products are no longer in commerce.
FOR IMMEDIATE RELEASE – October 22, 2023 – El Paso, TX. Botanical-Be is voluntarily recalling of all lots of Kuka Flex Forte, Capsules, Artri King, Capsules, and Reumo Flex, Capsules to the consumer level. FDA analysis has found the Kuka Flex Forte, capsules, Artri King, capsules, and Reumo Flex, capsules, to be tainted with Diclofenac. Diclofenac is an approved non-steroidal anti-inflammatory drug (NSAID), the presence of Diclofenac in Kuka Flex Forte, Artri King, and Reumo Flex renders them unapproved drugs for which safety and efficacy have not been established and, therefore, subject to recall. Risk Statement: Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as Warfarin, in those who have allergies to diclofenac, or those with underlying cardiovascular, gastrointestinal, renal, and hepatic illnesses. To date, Botanical-Be has not received any reports of adverse events related to this recall.
BUCKSPORT – Greenhead Lobster Products is voluntarily recalling all frozen and refrigerated cooked lobster meat products produced from May 9, 2023, through October 19, 2023, due to the potential for the product to be contaminated by Listeria monocytogenes.Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can cause miscarriages and stillbirths among pregnant women.
FOR IMMEDIATE RELEASE – 10/13/2023 – Select Custom Solutions is conducting a voluntary recall because Jay Robb Vanilla Flavored Egg White Protein 24 oz, lot 23080-2C2 with a time stamp of 09:00 to 12:00 may contain hard plastic foreign material which could pose a choking hazard. This product was sold nationwide through online order retail sale outlets.
This action relates only to Jay Robb Vanilla Flavored Egg White Protein 24 oz pouches with the following lot code and time stamps printed on the package: a. 23080-2C2 with a time stamp of 09:00 to 12:00 No other lot codes of Jay Robb products or any other Select Custom Solutions products are involved in this action.
FOR IMMEDIATE RELEASE – 10/13/2023 – Select Custom Solutions is conducting a voluntary recall because Jay Robb Vanilla Flavored Egg White Protein 24 oz, lot 23080-2C2 with a time stamp of 09:00 to 12:00 may contain hard plastic foreign material which could pose a choking hazard. This product was sold nationwide through online order retail sale outlets.
This action relates only to Jay Robb Vanilla Flavored Egg White Protein 24 oz pouches with the following lot code and time stamps printed on the package: a. 23080-2C2 with a time stamp of 09:00 to 12:00 No other lot codes of Jay Robb products or any other Select Custom Solutions products are involved in this action.
October 23, 2023 – Gills Onions of Oxnard, CA is voluntarily recalling Gills Onions branded fresh diced onions products because they have the potential to be contaminated with Salmonella, an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis. Symptoms usually occur within 12 to 72 hours after eating contaminated food and usually last four to seven days.Consumers: The recalled products, which were sent to Arizona, California, Idaho, Montana, Oregon and Washington, are identified in the table below. These recalled products are well beyond their August 2023 use-by-dates, and are no longer available for sale in stores.
** Utopia Foods Inc of Glendale, NY, is recalling all lots within expiry of Qilu Enterprise branded 200g packages of “Enoki Mushrooms” because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria monocytogenes infection can cause miscarriages and stillbirths among pregnant women.
The recalled Enoki Mushrooms were distributed to produce wholesalers in NY, NJ, PA, MA and MD. Products may have been further distributed to retail locations such as grocery stores.
The product comes in a 200g, clear plastic package with barcode 8928918610109 marked on the packaging. All products within expiry are included in the recall and were distributed between 8/7/2023 and 10/20/2023.
No illnesses have been reported to date in connection with this problem.
The potential contamination was noted by a routine sampling conducted by the State of West Virginia on products which were further distributed by Utopia’s customers bearing expiration date 10/26/2023. The products tested positive for Listeria monocytogenes.
October 20, 2023 – Baker Farms of Norman Park, GA is voluntarily recalling a single production run of Kroger 16-ounce bagged Collard Greens, due to possible Listeria monocytogenes contamination.
Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. To date, there have been no reports of illness related to the consumption of this bagged collard green product.
**
** Tiffany Food Corp of Brooklyn, NY is recalling all codes and flavors of Mini Fruit Jelly Cups, because they may pose a choking hazard. Small jelly cups containing konjac powder have previously been implicated in choking deaths of children.
Konjac and its consequent texture and consistency could pose a choking hazard to small children as well as adults with functional and/or anatomic abnormalities predisposing them to dysphagia.
The recalled jelly cups were distributed directly to Supermarkets within Pennsylvania, New Jersey and New York State.
The jelly cups are individually sealed and packaged in large clear jars. Below are the products being recalled:
Lychee, 4 714379 320992, 52.9 oz, All lot codes
Mango, 4 714379 321005, 52.9 oz, All lot codes
Assorted, 4 714379 320985, 52.9 oz, All lot codes
No incidents of consumers choking have been reported to date in connection with these products.
The potential choking hazard was confirmed after discussion with a representative from the Food and Drug Administration.
Consumers who have purchased the above products are urged to return them to the store of purchase for a full refund or dispose them in a sealed package inside a secure garbage can with a tight-fitting lid. For more information or inquiries, please contact the company at (347)-628-8588 Monday thru Friday between 8:30 am and 5:30 pm EST.
NOTE: McGRATH™ MAC video laryngoscopes purchased directly from Medtronic or via its authorized distributors are not affected by this safety notice. September 28, 2023– Medtronic is issuing this notification to inform the public of stolen defective McGRATH™ MAC video laryngoscopes that have been offered for sale illegally by unauthorized third parties through various social media platforms. These affected products did not pass Medtronic’s rigorous quality tests established for the product, were not released for sale, distribution, or importation and were designated for destruction. These affected products are defective and should not be used. Medtronic is working closely with regulatory authorities and law enforcement organizations to help ensure that unauthorized advertisements are being removed as identified, and actions to recover the stolen defective products are underway.
East Coast Food Distributors, Inc., the importer of record located in Hudson, N.H., is recalling approximately 7,767 pounds of pork chicharrones products. The products were imported from Colombia, a country ineligible to export meat products to the United States.
According to researchers, at least two patients in a botulism outbreak in France remain in hospital. The study covered eight individuals from four countries admitted to the intensive care unit at Bordeaux University Hospital, where six required invasive mechanical ventilation. Cases reported consuming locally produced canned sardines at a Tchin Tchin Wine Bar restaurant. As… Continue Reading
Family Dollar is initiating a voluntary retail-level product recall of certain over-the-counter drugs and medical devices regulated by the U.S. Food and Drug Administration (FDA). These items were stored outside of labeled temperature requirements by Family Dollar and inadvertently shipped to certain stores on or around June 1, 2023 through September 21, 2023. These items were sold at those stores between June 1, 2023 and October 4, 2023.
To date, Family Dollar has not received any consumer complaints or reports of illness related to this voluntary recall. This recall is being conducted out of an abundance of caution.
A list of the recalled products is attached. This recall goes to the retail store level. Not all of the products listed were sent to all stores. Family Dollar has notified its affected stores asking them to check their stock immediately and to quarantine and discontinue the sale of any affected product. Customers who purchased affected product may return such product to the Family Dollar store where they were purchased without receipt. This recall only applies to the following 23 states as no Family Dollar stores in any of the other states received any products subject to this recall: AL, AR, AZ, CA, CO, FL, GA, ID, KS, LA, MS, MT, ND, NE, NM, NV, OK, OR, SD, TX, UT, WA, and WY.
**
** September 29, 2023 – Charlottesville, VA – Biomic Sciences is voluntarily recalling all lots of ION* Sinus Support, ION* Sinus, and Restore Sinus Spray products to the consumer level. FDA testing found the product to contain microbial contamination identified as Microbacterium sp., Fictibacillus sp., Bacillus sp., (primarily B. malikii), and Paenibacillus sp (these microorganisms are generally non-pathogenic).
Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.
Parties with questions about this recall can contact ION* Sinus Recall Team at 1-844-715-0113 Monday – Friday from 9:00 am to 5:00 pm Eastern time or sinusrecall@intelligenceofnature.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.
The product is used as a nasal rinse and is packaged in individual boxes of one or two nasal spray dispensers (see the product pictures below). All lots of the of the following products are covered by this recall:
Eagle Produce LLC Scottsdale, AZ is initiating a voluntary recall of 6,456 cases of whole cantaloupe with the potential to be contaminated with Salmonella following a test conducted on cantaloupe in a distribution center by the FDA. Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy people may experience fever, nausea, vomiting, diarrhea (which may be bloody), and abdominal pain. In rare cases the organism can get into the bloodstream and producing more severe illness such as arterial infections (i.e. infected aneurysms), endocarditis and arthritis.
FOR IMMEDIATE RELEASE – October 2, 2023 – NEW YORK, NY., Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10mL vial; 1% Lidocaine HCl Injection, USP, 50 mg/5mL vial; and 2% Lidocaine HCl Injection, USP, 100 mg/5mL vial to the user level. The recall was initiated due to the potential for presence of glass particulate matter. There is an unlikely probability for serious adverse events, including death, should a patient receive an injectable product found to contain particulate matter identified as glass. Potential complications related to injection of visible and subvisible inert particles include inflammation of a vein, granuloma, and blockage of blood vessels or life-threatening blood clot events. The frequency and severity of these adverse events could vary depending upon a variety of factors including the size and number of particles in the drug product, patient comorbidities (such as age, compromised organ function), and presence or absence of vascular anomalies. The risk is reduced by the possibility of detection, as the label contains a clear statement directing the healthcare professional to visually inspect the product for particulate matter and discoloration prior to administration.
JERSEY CITY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. is conducting a voluntary nationwide recall of 2 lots of BREXAFEMME® (ibrexafungerp tablets) to the consumer level in the US market due to potential cross contamination with a non- antibacterial ß-lactam drug substance in the ibrexafungerp citrate used to manufacture the BREXAFEMME® tablets. During a review of manufacturing equipment and cleaning activities at a supplier, SCYNEXIS was made aware of potential cross-contamination risk with a non-antibacterial beta-lactam drug substance. This press release provides additional details on the voluntary product recall recently disclosed by SCYNEXIS.Risk Statement: The potential cross contamination with a non-antibacterial beta-lactam drug substance could lead to hypersensitivity reactions such as swelling, rash, urticaria and anaphylaxis, a potentially life-threatening adverse reaction. To date, SCYNEXIS has not received any reports of adverse events established to be due to the possible beta-lactam cross contamination.
FOR IMMEDIATE RELEASE – 09/29/2023 – Newtown, Pennsylvania, KVK-Tech, Inc. is voluntarily recalling one lot (Batch Number: 17853A; “the batch”) of Betaxolol Tablets, USP 10 mg, White, Round, film coated biconvex tablets, debossed “K” above bisect “13” on one side and plain on the other side” to the consumer level. The batch was distributed nationwide to wholesalers and retailers. The batch is being recalled as a precautionary measure due to a single Oxycodone HCl tablet 5 mg foreign tablet found on the packaging line during the line clearance after the subject batch was packaged. KVK has not received any reports of foreign tablet in any bottle of Betaxolol Tablets, USP 10 mg (Batch Number 17853A) at this time.Risk Statement: The betaxolol package insert warns about slowing in the heart rate in elderly patients which is likely to be exacerbated by inadvertent opioid administration. Additionally, some patients prescribed low-dose betaxolol might be have compromised heart and lung function that is also likely to be exacerbated by an opioid.
FOR IMMEDIATE RELEASE – September 29, 2023 – Charlottesville, VA – Biomic Sciences is voluntarily recalling all lots of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray products to the consumer level. FDA testing found the product to contain microbial contamination identified as Microbacterium sp., Fictibacillus sp., Bacillus sp., (primarily B. malikii), and Paenibacillus sp (these microorganisms are generally non-pathogenic).Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.
Costco is recalling Organic Chicken Bone Broth sold between Sept.8, 2022, through Sept. 22, 2023.
“The product may have the potential for non-pathogenic microbial contamination, which may result in product bloating, shortened shelf-life, and potential…Continue Reading
**
** TOPIC: Risk of Invasive Disease in Preterm Infants Given Probiotics Formulated to Contain Live Bacteria or Yeast AUDIENCE: Consumers, Patients, Health Professionals, Pediatrics, Gastroenterology ISSUE: The U.S. Food and Drug Administration (FDA) is providing important safety information to healthcare providers on the use of products containing live bacteria or yeast (commonly called probiotics) in preterm infants in hospital settings. For more information about this alert, click on the red button “Read Alert” below. BACKGROUND: FDA has issued a Dear Healthcare Provider (DHCP) Letter to provide important safety information to healthcare providers on the use of products containing live bacteria or yeast (commonly called probiotics) in preterm infants. The letter warns healthcare providers that preterm infants who are given probiotics are at risk of invasive, potentially fatal disease caused by the bacteria or fungi contained in probiotics, and includes information about a preterm infant who was administered Evivo with MCT Oil as part of in-hospital care who developed sepsis caused by the bacterium Bifidobacterium longum and subsequently died. RECOMMENDATIONS: The FDA cautions that microorganisms contained in probiotics have been reported in the medical literature as causing bacteremia or fungemia, sometimes with a severe clinical course, in very preterm or very low birthweight (VLBW) infants.1-4 Moreover, the American Academy of Pediatrics states “Given the lack of FDA-regulated pharmaceutical-grade products in the United States, conflicting data on safety and efficacy, and potential for harm in a highly vulnerable population, current evidence does not support the routine, universal administration of probiotics to preterm infants, particularly those with a birth weight of <1000 g.”5 The FDA is also reminding healthcare providers that FDA has not approved any probiotic product for use as a drug or biological product in infants. The FDA is aware that some unapproved, unlicensed probiotics are nonetheless sold for use to treat or prevent a disease or condition in infants, including to reduce the risk of necrotizing enterocolitis (NEC) in preterm infants. Healthcare providers should be aware that these products have not undergone the FDA’s rigorous premarket review evaluation for safety and effectiveness, nor have they been evaluated for compliance with the agency’s rigorous manufacturing and testing standards for drugs and biological products, including testing for extraneous organisms. The FDA reminds healthcare providers who administer probiotics containing live bacteria or yeast to treat, mitigate, cure, or prevent a disease or condition that they are required to submit an Investigational New Drug Application (IND) to the agency. References: ¹⁻⁴ Case reports of bacteremia and fungemia from probiotic use in preterm infants: https://pubmed.ncbi.nlm.nih.gov/27532215/, https://pubmed.ncbi.nlm.nih.gov/25472946/, https://pubmed.ncbi.nlm.nih.gov/28133894/, https://pubmed.ncbi.nlm.nih.gov/32859326/ ⁵ Poindexter B. Use of probiotics in preterm infants. Pediatrics 2021;147(6):June 2021:e2021051485. https://publications.aap.org/pediatrics/article/147/6/e2021051485/180282/Use-of-Probiotics-in-Preterm-Infants A copy of the DHCP letter can be found on FDA’s website here or at: 2023 Safety and Availability Communications | FDA
Consumers, health professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online. Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.
Be a Seed for Change 
You must be logged in to post a comment.